Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
46.58
-6.42 (-12.11%)
Nov 13, 2026, 3:00 PM CST

SHA:688799 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
211.12203.78177.74379.65191.29353.39
Short-Term Investments
-50296.78349.66181.66-
Trading Asset Securities
501018315325400
Cash & Short-Term Investments
261.12263.78657.52744.31697.95753.39
Cash Growth
-11.77%-59.88%-11.66%6.64%-7.36%853.42%
Accounts Receivable
255.86279.1226.19183.54180.54129.2
Other Receivables
4.853.2116.52.142.191.49
Receivables
260.72282.31242.69185.68182.73130.68
Inventory
397.86392.46412.43362.67339.26300.53
Prepaid Expenses
-3.132.481.111.832.49
Other Current Assets
144.33234.54118.1555.9826.5718.89
Total Current Assets
1,0641,1761,4331,3501,2481,206
Property, Plant & Equipment
1,4761,003687596.78563.76472.98
Long-Term Investments
860.85542.1943.4947.1536.0534.11
Goodwill
--32.3832.3832.38-
Other Intangible Assets
168.99168.59186.0976.6281.0657.56
Long-Term Deferred Tax Assets
27.1140.4539.8118.7314.212.29
Long-Term Deferred Charges
47.2624.9410.445.323.260.23
Other Long-Term Assets
50.3198.5727.1450.2129.9214.38
Total Assets
3,6943,0542,4602,1772,0091,798

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
264.55181.53139.9289.571.1380.9
Accrued Expenses
17.1737.0624.5126.0420.6172.81
Short-Term Debt
--3.77---
Current Portion of Long-Term Debt
1.660.370.050.01--
Current Income Taxes Payable
4.834.3813.329.971.290.94
Current Unearned Revenue
66.3272.4888.9980.1382.4162.75
Other Current Liabilities
231.93114.88148.46130.73119.442.19
Total Current Liabilities
586.46410.7419.02336.38294.83259.59
Long-Term Debt
857.58497.6113.9317.11--
Long-Term Unearned Revenue
100.79102.6598.849.9453.1956.92
Long-Term Deferred Tax Liabilities
--0.02-2.330.01
Other Long-Term Liabilities
--5.285.28-1.55
Total Liabilities
1,5461,011637.06408.7350.35318.07

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
133.64131.3293.893.893.893.8
Additional Paid-In Capital
914.37870.1850.34850.34850.34850.34
Retained Earnings
1,1001,041859.27779.37652.47535.33
Total Common Equity
2,1482,0431,8031,7241,5971,479
Minority Interest
--19.1744.7362.01-
Shareholders' Equity
2,1482,0431,8231,7681,6591,479
Total Liabilities & Equity
3,6943,0542,4602,1772,0091,798

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
860.32497.98117.7517.12--
Net Cash (Debt)
-599.21-234.2539.77727.19697.95753.39
Net Cash Growth
---25.77%4.19%-7.36%853.42%
Net Cash Per Share
-4.39-1.744.115.535.326.73
Filing Date Shares Outstanding
130.58131.32131.32131.32131.32131.32
Total Common Shares Outstanding
130.58131.32131.32131.32131.32131.32
Working Capital
477.55765.521,0141,013953.5946.38
Book Value Per Share
16.4515.5613.7313.1212.1611.27
Tangible Book Value
1,9791,8741,5851,6151,4831,422
Tangible Book Value Per Share
15.1614.2712.0712.2911.2910.83
Buildings
-467.65316.97325.35313.1304.86
Machinery
-581.56539.11491.33372.49274.63
Construction In Progress
-323.73143.0627.6270.543.05